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Purpose. Albinism is a clinically and genetically heterogeneous condition. Despite analysis of the 
twenty known genes, ~30% patients remain unsolved. We aimed to identify new genes involved in 
albinism. 
Methods. We sequenced a panel of genes with known or predicted involvement in melanogenesis in 
230 unsolved albinism patients. 
Results. We identified variants in the Dopachrome tautomerase (DCT) gene in two patients. One was 
compound heterozygous for a 14 bp deletion in exon 9 and c.118T>A p.(Cys40Ser). The second was 
homozygous for c.183C>G p.(Cys61Trp). Both patients had mild hair and skin hypopigmentation, and 
classical ocular features. CRISPR-Cas9 was used in C57BL/6J mice to create mutations identical to the 
missense mutations carried by the patients, along with one loss-of-function indel mutation. When 
bred to homozygosity the three mutations revealed hypopigmentation of the coat, milder for 
Cys40Ser compared to Cys61Trp or the frameshift mutation. Histological analysis identified 
significant hypopigmentation of the retinal pigmented epithelium (RPE) indicating that defective RPE 
melanogenesis could be associated with eye and vision defects. DCT loss of function in zebrafish 
embryos elicited hypopigmentation both in melanocytes and RPE cells. 
Conclusions. DCT is the gene for a new type of oculocutaneous albinism that we propose to name 
OCA8. 
 





In humans, albinism defines a group of genetic diseases commonly subdivided into three main types: 
oculocutaneous albinism (OCA), ocular albinism (OA) and syndromic albinism (Hermansky-Pudlak 
syndrome, HPS, and Chediak-Higashi syndrome, CHS)1,2. Generalized hypopigmentation of the skin 
and hair is highly variable among patients, ranging from total absence of melanin to undetectable 
defects in pigmentation. On the other hand, ophthalmological anomalies are more consistently 
detected and are therefore considered to be central in the definition of human albinism. These 
include iris and/or retinal hypopigmentation, nystagmus, foveal hypoplasia, chiasm misrouting of the 
optic nerves, and overall reduced visual acuity. Krujit et al. described major and minor criteria and 
proposed that patients should display three major criteria or two major criteria and two minor 
criteria for the diagnosis of albinism to be ascertained 3. 
Albinism is also genetically heterogeneous since 20 genes are so far known to be involved (6 for OCA, 
1 for OA, 1 for the closely related FHONDA, 11 for HPS, 1 for CHS) 2,4–6. Despite a systematic search 
for both single nucleotide variants and copy number variants in 19 of these genes, 27% of patients 
remain without a molecular diagnosis 5.  
We and others have shown that over 50% of OCA patients with molecular diagnosis have a mutation 
in TYR (OCA1) encoding tyrosinase while around 2-3% have a defective TYRP1 (OCA3) encoding 
tyrosinase related 1 protein 1,5,7–9. Both enzymes are well known to control pigment synthesis 10. Of 
note, a third enzyme, dopachrome tautomerase, DCT acts downstream of TYR but upstream of TYRP1 
on the DHICA melanin synthesis pathway 11,12 making the corresponding gene (DCT/TYRP2) an 
obvious candidate for human albinism. However, pathogenic variants in DCT/TYRP2 have not yet 
been reported. 
In the present study, we screened a series of 230 unsolved patients for pathogenic variants among a 
selection of candidate genes including DCT/TYRP2. We describe two patients with classical ocular 
albinism and mild hypopigmentation of the skin, hair and eyes who both have potential pathogenic 
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DCT/TYRP2 genotypes. We further validate these variants by analyzing the phenotypes of genetically 
modified mice lines and zebrafish embryos.  
This work is the first evidence that mutations in DCT/TYRP2 can cause oculocutaneous albinism in 
humans. We therefore propose that DCT/TYRP2 is now associated to a new OCA subgroup, OCA type 
8 (OCA8). 
 
MATERIALS AND METHODS  
Patients. 
This study was approved by the local authority (Comité de Protection des Personnes Sud Ouest et 
Outre Mer III). Informed consent was obtained from the patients and/or their parents in the case of 
minors before genetic analysis was performed. Authorization for publication was obtained from 
Patient 1. Patient 2 was lost from contact and authorization was not collected, but the patient cannot 
be identified on the basis of data published here.  
Sequencing of candidate genes. 
DNA was extracted from peripheral blood leukocytes using an automated procedure (Tecan EVO-
ReliaPrep, Promega). Next Generation Sequencing (NGS) was performed using the ionTorrent 
technology on a S5XL instrument (Life Technologies, ThermoFischer Scientific, U.S.A.) (AmpliSeq 
panel) and bioinformatics analysis of variants were as previously described 5. DCT variants 
(NM_001129889.2) were confirmed by Sanger sequencing. See Supplementary Data for more details.  
CRISPR modelling of Dct variants in the mouse. 
Mouse lines: All mouse work was carried out in compliance with United Kingdom Home Office 
regulations under a United Kingdom Home Office project license. To create the Dct118 A/A, Dct183 
G/G and Dct -/- alleles the CRISPR design site https://chopchop.cbu.uib.no/ (in the public domain) 
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was used to design guides with default settings (g1 for Dct118 A/A and g2 for Dct183 G/G and Dct -/-, 
Supplementary Materials). Genetic engineering of CRISPR-Cas9 lines with each of the Cys 
substitutions was performed as already described 13 and detailed in Supplementary Materials and 
Methods. 
Direct spectrophotometry of Dct mice: Coat colour of live mice, aged between 1 and 2 months, was 
measured by direct spectrophotometry using Konica Minolta CM-2600d, as already described 14 and 
detailed in Supplementary Materials and Methods. Between 5 and 9 animals were studied, 
depending on the strain. 
Eye histology:  Mice were sacrificed by cervical dislocation and eyes enucleated and processed as 
detailed in Supplementary Materials and Methods. 
Randomization was not required, since comparison was between genotypes not treatments. 
Spectrometric measurements were carried out blind to genotype. 
dct knock-down in Danio rerio. 
dct targeting: Zebrafish (D. rerio) were produced in accordance with the French Directive (Ministère 
de l'Agriculture) and in conformity with the European Communities Council Directive (2010/63/EU). 
The zebrafish homolog of DCT was identified by searching in the genome sequence database at 
http://www.ensembl.org/Danio_rerio taking into account the synteny with the human genome. 
Morpholino (MO) were designed by and obtained from GeneTools, LLC and embryo injection is 
detailed in Supplementary Materials and Methods. 
Melanin assay was based on already described methods 15 and detailed in Supplementary Materials 
and Methods. 







Identification of DCT variants in patients with oculocutaneous albinism. 
We recently described the analysis of 990 index cases with albinism and showed that a molecular 
diagnosis could be obtained after analysis of the 19 albinism genes known at that time in 72% of 
patients 5. Our cohort nowadays comprises more than 1500 patients, amongst whom the proportion 
of patients remaining without a molecular diagnosis is in the 25-30% range. Following the hypothesis 
that some of these patients may have pathogenic variants in genes other than the 19 already 
identified, we screened the genomes of 230 undiagnosed patients for variants in candidate genes 
selected for their known or predicted involvement in melanogenesis, including orthologues of mouse 
mutants with pigmentary defects (see Supplementary Table 1). We recently described the finding of 
BLOC1S5 variants in two patients with Hermansky-Pudlak Syndrome (HPS11)6. 
Here, we identified homozygous or compound heterozygous variants of the Dopachrome 
tautomerase (DCT) gene (NM_001129889.2), also called Tyrosinase-related protein 2 (TYRP2), in two 
patients.  
Patient 1, a 12 years old girl born to unrelated parents of French origin, was diagnosed at the age of 3 
years, and presented with moderate hypopigmentation of the skin and hair, congenital nystagmus, 
moderate foveal hypoplasia grade I 16, iris transillumination and hypopigmentation of the retina 
(Figure 1). Her visual acuity was 5/10 in both eyes. She harbored a single nucleotide variant in exon 1 
of DCT, c.118T>A p.(Cys40Ser) (ClinVar submission number SUB7603838), that was inherited from 
her heterozygous father, and a 14 bp deletion in exon 9, c.1406_1419del p.(Phe469*) (ClinVar 
submission number SUB7603850), inherited from her heterozygous mother. Patient 2 (age at 
diagnosis not known) is a woman aged 36 at the time of consultation who was born to 
consanguineous parents originating from Northern Africa. She had cream-coloured skin, light brown 
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hair, nystagmus, photophobia, iris transillumination, hypopigmentation of the retina and reduced 
visual acuity (4/10 and 5/10). Morphology of the fovea was not investigated. Patient 2 was 
homozygous for variant c.183C>G p.(Cys61Trp) (ClinVar submission number SUB7603854) in DCT 
exon 1 (Figure 1). Segregation analysis could not be completed and no further information on her 
phenotype could be gathered, as she was lost from contact after DNA sampling. All three variants 
were predicted to be deleterious by several prediction software (see Materials and Methods) taking 
into account parameters such as allele frequency in public genome databases, conservation, as well 
as effect on protein structure and physicochemical properties. All three variants are classified as 
likely pathogenic according to the criteria of the American College of Medical Genetics 17 : c.118T>A 
p.(Cys40Ser) (PS3, PM2, PP3, PP4), c.1406_1419del p.(Phe469*) (PM2, PM4, PP3, PP4), c.183C>G 
p.(Cys61Trp) (PS3, PM2, PP3, PP4). 
The c.1406_1419del p.(Phe469*) out of frame deletion present in Patient 1 is predicted to result 
either in a truncated DCT protein lacking the transmembrane domain which is necessary for 
anchoring the protein in the melanosomal membrane or in mRNA nonsense mediated decay.  
Notably, both single nucleotide variants found in the two patients, c.118T>A p.(Cys40Ser) and 
c.183C>G p.(Cys61Trp) affect highly conserved cysteine residues located in exon 1 of the gene and 
belonging to a Cys-rich domain that is part of an EGF-like domain with 5 potential disulfide bonds 
(Figure 2). 
These findings suggest that the three DCT variants identified are pathogenic and responsible for the 
albinism phenotype of the two patients described here. In order to further evaluate their 






CRISPR modelling of Dct variants in the mouse. 
In addition to the Dct mouse knock-out line that was described by Guyonneau et al. 18, three different 
missense variants have been shown to be responsible for the greyish (slaty) color of mouse hair 12,19. 
As indicated in Figure 2, none of these mutations are equivalent to the patients’ variants identified in 
this study. We therefore decided to genetically engineer CRISPR-Cas9 lines with each of the Cys 
substitutions. 
Two lines were obtained with the exact equivalent changes to human p.(Cys40Ser) [mouse c.118T>A 
p.(Cys40Ser)] and human p.(Cys61Trp) [mouse c.183C>G  p.(Cys61Trp)]. Targeting of base pair 183 
also led to a fortuitous out of frame 5bp deletion (c.171_175del) in one founder that was brought to 
homozygosity as a loss of function control Dct-/- (frameshift results in premature stop codon at 
position 78, see Supplementary data). 
Mice heterozygous for any of the three mutations had a normally pigmented (black, nonagouti) fur. 
We crossed each line to produce homozygous mice which were grown to adulthood and all mice 
displayed dark-grey hair, apparently identical to that seen in the previously described mutations of 
Dct (Figure 3A). The colour difference between mutant and control was much clearer in the ventral 
hair. The mouse ventrum is often paler than the dorsum, even in non-agouti mice such as these. Non 
hairy skin (pinna and tail) of mutants are not obviously paler than control. In order to more precisely 
quantify the pigmentary changes we colorimetrically assayed the dorsal coat of the mutants in three-
dimensional CIELAB colour space, measuring along light-dark, blue-yellow and red-green axes (Figure 
3B). All three lines were very different from the parental C57BL6/J mice. In addition, the Cys61Trp 
mice and the deletion mice were indistinguishable in all three dimensions. Interestingly, although not 
apparently different by eye, the mice homozygous for Cys40Ser were consistently less severely 
affected than the Cys61Trp and deletion mice in all three dimensions.  
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These observations in mice strongly suggest that the missense variants identified in both patients 
cause loss or partial loss of function of DCT and that this is the cause of their hypopigmentation of 
the hair and skin. 
Dct knock-out and slaty mice have hardly been investigated for ophthalmological anomalies. We 
conducted histological analysis of eyes from adult Dct -/- mice. Gross anatomy of the eye was not 
modified in these mice as compared to wild-type (C57Bl/6J) age-matched controls although we 
cannot rule out that the outer nuclear layer was slightly thinner and disorganized in some Dct-/- 
retinas (not shown). Melanocytes in the choroidal layer appeared normally pigmented. However, 
careful examination of the outer retina evidenced that the RPE in Dct-/- mice was significantly less 
pigmented than in wild-type retinas. As illustrated in Figure 3C, dark melanin in the control eye 
completely masks the RPE cell membranes and contents whereas in Dct-/- eyes, pigmentation of the 
RPE is light enough that hematoxylin stained nuclei can be visualized in most of the RPE cells.  
Altogether, these results show that when introduced in mice, Cys40Ser and Cys61Trp mutations 
result in hypopigmentation of the coat, the latter being undistinguishable from complete loss of 
function. Furthermore, RPE melanin content is reduced in Dct-/- mice, which may cause eye and 
vision anomalies in mice, and, in a similar way, in DCT patients.  
 
dct knock-down in Danio rerio. 
Loss of function of dct was also investigated in zebrafish (D. rerio) embryos in which development 
and pigmentation of skin melanophores and RPE can be followed in vivo. Of note, only one DCT 
homologue is found in D. rerio genome and D. rerio protein sequences are highly conserved with 62% 
identity and more than 85% similarity (Figure 2). The expression of dct was transiently knocked down 
using a morpholino (MO). Compared with embryos injected with MO-ctrl, MO-dct injected embryos 
did not show macroscopic phenotype disruption and no obvious disruption of skin melanophores 
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pattern at neither 48 hpf nor 120 hpf (Figure 4A,C). However, melanophores dorsally localized at the 
head level of 48 hpf MO-dct appeared lighter and wider than those of controls (Figure 4A). Eye 
pigmentation was also slightly lighter in dct knocked-down embryos (Figure 4A). In order to quantify 
a visible hypopigmentation, a whole-embryo melanin assay was performed, confirming a ≈30% 
significant decrease of total melanin in dct-knockdown embryos versus control embryos (Figure 4B). 
Later in development at 120 hpf, MO-dct embryos still presented with a normal pattern of skin 
melanophores. However, their intracellular pigmentation was different from controls. In control 
embryos, pigmentation of melanophores appeared highly packed as expected whereas pigmentation 
in MO-dct embryos melanophores was consistently weaker and showed an abnormal stellar pattern 
(Figure 4C). In addition to general pigmentation disruption, significant microphthalmia was noticed  
possibly due to off-target effect or toxicity, although other indicators for toxicity ie shape and size of 
the embryos, were not significantly affected20 (Figure 4D). Histological sectioning of 48 hpf embryos 
(Figure 4A) evidenced eye developmental defects. In MO-Ctrl injected embryos, stratification of the 
neural retina into outer and inner layers was achieved by 48 hpf whereas at the same stage, MO-dct 
eyes still displayed only one homogeneous layer of neurons. The RPE in morphants was clearly 
hypopigmented, but in addition instead of the normal organization as a heavily pigmented 
cobblestoned single cell layer, the RPE showed dishevelled cells and wavy contours.  
Altogether, these data are complementary to the observations made in mice, and confirm that loss 
of function of Dct impairs melanin metabolism in both melanocytes and in RPE cells of early embryos 
in D. rerio with possible consequences on eye development and/or function. 
 
DISCUSSION 
We report the identification of pathogenic variants in the DCT gene in two unrelated patients with 
oculocutaneous albinism. Two of them are missense variants affecting highly conserved cysteine 
residues that belong to a Cys-rich domain [c.118T>A p.(Cys40Ser) and c.183C>G p.(Cys61Trp)]. The 
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third variant is a 14 bp out-of-frame deletion [c.1406_1419del p.(Phe469*)], a likely null allele. Both 
patients presented with a creamy skin and light brown hair, thus indicating that melanin is produced 
to a significant level. Visual acuity was moderately reduced (4/10 - 5/10) in both patients. The ocular 
phenotype included nystagmus, hypopigmentation of the retina and iris transilllumination. Foveal 
hypoplasia was of low grade in patient 1 and not investigated in patient 2. 
This is the first time DCT variants have been shown to cause oculocutaneous albinism in human.  
Dopachrome Tautomerase (DCT), formerly known as Tyrosinase Related Protein 2, is one of three 
members of the tyrosinase protein family, along with TYR and TYRP1. All three are enzymes 
catalysing reactions in the melanogenesis pathway, and are located within melanosomes, a pigment 
cell-specific organelle 10. In this series of reactions as previously reviewed10, Tyrosinase (TYR) 
catalyses the initial conversion of tyrosine to dihydroxyphenylalanine (DOPA) and DOPA to 
DOPAquinone, which spontaneously cyclises to DOPAchrome. DCT catalyses the tautomerisation of 
DOPAchrome to dihydroxyindole carboxylic acid (DHICA). DOPAchrome can also spontaneously lose 
the carboxyl group to produce dihydroxyindole (DHI). The function of the third member of the family, 
Tyrosinase-related Protein 1 (TYRP1) is still not completely certain and may vary depending upon 
species and/or cell types. It probably acts, maybe in conjunction with TYR, to oxidise DHICA and DHI, 
by removing the two hydroxyl groups to the indole derivatives which ultimately polymerise to form 
melanin on a protein matrix within the melanosome. The melanins formed from DHICA and DHI are 
eumelanins, which range in colour from brown to black. 
As TYR is the key limiting enzyme in melanogenesis, its absence results in complete lack of melanin, 
as seen in mutant mice and humans with OCA1. Absence of TYRP1 in mice results in the production 
of brown eumelanin, which appears to be less polymerised than black eumelanin. The human TYRP1 
gene is mutated in patients with OCA3. The effect on pigmentation, and ocular defects, are relatively 
mild with bright copper-red coloration of the skin and hair, both in African and European patients 5,21. 
Curiously, despite being upstream of TYRP1, the absence of DCT in mice results in a darker eumelanin 
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than the brown eumelanin that lacks end-products generated in the presence of TYRP1. This is most 
likely due to DOPAchrome being converted to DHI, which produces a dark eumelanin. Absence of 
TYRP1 in presence of DCT means that DHICA, rather than its oxidised derivative, is polymerised to 
produce the brown eumelanin observed. A milder phenotype than the average OCA3 type is 
therefore expected in humans with a loss of DCT function. 
The two missense mutations identified in this study are located in the N terminal Cys-rich subdomain 
of DCT which is strikingly conserved in its two paralogues TYR and TYRP1 and across species (Figure 
2). Localisation of the ten cysteine residues (C1 to C10) in each enzyme is indicated in Table 1 as well 
as their participation in the 5 disulfide bonds that stabilize the domain 10. 
Note that C3 to C8 (involved in disulfide bonds 2, 3, 4) belong to the highly conserved EGF-like 
signature. According to the Human Gene Mutation Database, amongst 354 missense and nonsense 
mutations in TYR, substitutions in all of the C1 to C10 cysteine residues are found associated with 
OCA1. Of particular interest, C2 [patient 1 variant p.(Cys40Ser)] is mutated in two unrelated OCA1 
Pakistani patients 22, and C5 [patient 2 variant p.(Cys61Trp)] is also mutated in OCA1 patients with 3 
identified variants 23–25. Interestingly one of the OCA1 patients with a C2 substitution described by 
Jaworek et al. 22 is homozygote for a Cys to Arg change and has a somewhat mild phenotype (fair 
blond hair and pinkish skin) compared with known complete loss of function. Moreover, this mutated 
TYR has a temperature-sensitive behaviour likely due to slight protein misfolding. Whether this is due 
to loss of disulfide bond 1 and is therefore to be expected whatever amino acid is substituted at C1 
or C2 would require further structural or functional investigations. Interestingly, the only allele 
involving a cysteine change of the Cys-rich domain in OCA3 patients affects C1 of TYRP1 and has also 
been associated with impairment of traffic to the melanosomes 26.  
Altogether, these data suggest that disruption of disulfide bond 1 in TYR and/or TYRP1 is likely to 
result in less severe and possibly temperature sensitive misfolding of the mutated enzyme. Ablation 
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of bond 2 on the other hand may have a more detrimental effect on the structure of the whole 
enzyme as it is essential to stabilize the EGF-like domain. 
Given the high degree of conservation of tyrosinase related proteins between them and among 
species, we speculated that substitution of C2 and C5 in our DCT patients could have similar effects 
and investigated the corresponding phenotypes in mice. Supporting the relevance of this model for 
our comparative functional analysis, the two classical mutations of mouse in Tyr (albino) and Tyrp1 
(brown) are also in conserved cysteines of the Cys-rich domain, in tyrosinase at C9, Cys103Ser, 27,28 
and in Tyrp1 at C8, Cys110Tyr 29. We show that mutation of Dct C2 in mice appears to be less severe 
than either C5 or the null frameshift that was produced. Although the difference is not readily 
detectable visually, the subtle variation is clearly seen when the fur is analysed 
spectrophotometrically. It is tempting to attribute these differences to only a slight conformation 
change as in TYR and TYRP1. However structural models of DCT/TYRP2 are speculative at this point as 
no crystallographic data have been so far generated. 
Altogether these observations indicate a causal role of the C2 and C5 substitutions in our patients. 
The mild phenotype of patient 1 may be explained by a partial and possibly thermosensitive loss of 
function of DCT.  
Previous studies 18 have reported no effect of Dct mutations on mouse eye pigmentation. However, 
our close examination of mice with the null frameshift reveals a significant decrease in pigmentation 
of the RPE, although the choroid appears only mildly or not affected at all. How can this be related to 
some or all of the ophthalmic anomalies seen in the patients? Since our original demonstration that 
the RPE plays a key role in early development of the mammalian neural retina 30, a considerable 
amount of work has been performed, including in the albino Tyr-/- mouse, that sheds light on the 
primary cause for visual deficiency in OCA1 patients [for review see 31]. In particular it was shown 
that the lack of melanin and/or intermediates along the melanogenesis pathway leads to retinal 
developmental defects, especially in the neurogenesis of ganglion cells, and that defective guidance 
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of their axons along the optic tracts results in optic chiasm misrouting and impairment of binocular 
vision [for review see 32]. Despite extensive investigation 33,34, it is still not clear which factors in the 
pigment synthesis pathway are involved and if they directly signal from the RPE to the neural retina 
or if they primarily affect RPE integrity. The fact that the RPE of both Dct-/- mice and zebrafish dct 
morphants is hypopigmented, together with typical ophthalmological defects diagnosed in our two 
DCT patients supports the hypothesis that the fully functional melanin pathway in the early RPE is 
instrumental to retinal neurogenesis. 
The zebrafish embryo is a useful experimental model to study both skin and eye pigmentation as well 
as early eye development. Models for OCA1 and OCA3 have been described 35–37. Although dct 
expression pattern in zebrafish embryo has been used as a molecular marker of pigmented cells 38, its 
knock-down has not been previously described. Here we show that it results in hypopigmentation of 
both melanophores and RPE. In addition, instead of harbouring their usual pigmentation pattern, 
melanophores of the skin resemble those of wild-type embryos responding to hormone-driven 
adaptation to surrounding darkness by melanin dispersion 36, suggesting that dct knock-down may 
impair melanin aggregation or that MO treatment has affected intracellular signalling . In the RPE, in 
addition to hypopigmentation, cell integrity was obviously affected. Such a pleiotropic effect has 
been described previously 39. Further investigations will aim at confirming and studying these 
changes at the cellular and molecular levels during development both in mouse and zebrafish 
embryos. 
In conclusion, we report here the first evidence of DCT variants causing OCA in two unrelated 
patients. It is notable that both patients had mild hypopigmentation of the skin, hair and eyes and 
moderate loss of visual acuity. Albinism is clinically heterogeneous, and DCT patients seem to fall in 
the mild range of the phenotypical spectrum. These mild phenotypes may be overlooked by clinicians 
and lead to underdiagnosis of albinism. As we recently discussed 40, we advocate that minimal signs, 
both dermatologic and ophthalmologic, sometimes of atypical presentation, should be systematically 
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given consideration and lead to genetic investigations in order to establish a precise diagnosis. The 
DCT gene should now be included in albinism diagnosis gene panels. We propose that the 
corresponding form of OCA is called OCA8. 
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Figure 1: Phenotype and genotype of Patients 1 and 2. 
Photographs show the hypopigmentation of hair and skin of Patient 1 (A,B). Bilateral foveal 
hypoplasia is seen in Patient 1 (C: right eye; D: left eye), compared to a normal control (E) and a 
positive control (OCA1 patient) (F). Pedigree of Patient 1 shows inheritance of the two mutations 
from heterozygous parents (G). 
Pedigree of Patient 2 is shown in H. The patient’s consanguineous parents could not be tested 
because they were not available. 
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Figure 2. Amino acid sequences alignment for the Human tyrosinase family and DCT sequences of 
other species.  
In addition to Homo sapiens protein sequences of tyrosinase family including TYR, TYRP1 and TYRP2 
(DCT), DCT protein sequences of Mus musculus, Gallus gallus, Xenopus tropicalis and Danio rerio 
were aligned. Black shaded residues indicate more than 80% of identity whereas grey shaded 
residues indicate more than 80% of similarity. Black stars (*) highlight conserved cysteine residues. 
Black diamond indicates the position of the fortuitous out of frame 5bp deletion in the knockout 
mouse model produced in the present study (p.Asn78*). Above the sequence alignment, the grey 
line indicates the EGF-like domain whereas the black dotted lines indicate the metal ion-binding 
domains. The black lined box represents the transmembrane domain. Black dots under the alignment 
indicate the previously reported slaty mutations in mouse (slt: R194Q; slt2J: P434L; sltLt: G486R). 
Numbering under alignment indicates the cysteine bounds.  
 
Figure 3. Patient mutations have a visible effect on pigmentation of the coat and eyes in mice. 
(A) Dorsal (upper panel) and ventral (lower panel) view of Dct mutant mice compared to C57Bl/6J 
controls. Male mice are shown, approximately 3 months old. (B) Three-dimensional CIELAB colour 
measurement along light-dark, blue-yellow and red-green axes as indicated for Cys40Ser, Cys61Trp, 
Dct-/- and C57Bl/6J. For each measurement, the difference between any of the mutated strain and 
control was highly significant (T-test, p-values< 10-6), no significant difference was found between 
Cys61Trp and Dct-/- whereas Cys40Ser was significantly less affected than Cys61Trp (especially in the 
red-green pigment contents, p-value < 5.10-4). (C): histology of 2 month old retinas from Dct-/- and 
age-matched C57Bl/6J control mice. Fields were photographed at mid-distance between the optic 
nerve and ciliary body for both samples, scale bar 25m. One field is magnified to illustrate the 
significant difference in RPE pigmentation. Haematoxylin stained nuclei are clearly visible in Dct-/- 




Figure 4. dct is required for skin melanocytes and RPE development preservation in zebrafish D. 
rerio.  
(A) Representative lateral views of whole embryos (scale bar, 100µm), dorsal views of heads 
(scale bar, 100µm) and histological cross sections of eyes (scale bar, 20µm) from 
representative 48hpf zebrafish embryos injected with MO-ctrl or MO-dct. Bracket shows 
inner retina that has differentiated from outer retina in control but not in Mo-ctrl. (B) 
Melanin was quantified in 48hpf zebrafish embryos injected with MO-ctrl or MO-dct. Means 
were calculated from the data collected from three independent experiments, Mann-
Whitney test, *p < 0.05. (C) Representative lateral views of whole embryos at 120 hpf 
injected with MO-ctrl or MO-dct. Insets represent enlarged views of skin melanocytes 
laterally localized in the trunk. (D) Embryo length (reported on left y axis) and left eye area 
(right y axis) were measured from one representative experiment on MO-ctrl group (n=12) 
and MO-dct group (n=28). Mann-Whitney test was applied for length data whereas unpaired 




Table 1: Conserved Cysteine residues across the TYR/TYRP1/DCT family. 
 EGF-like signature  
Cys C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
DCT 29 40 41 52 61 95 97 107 109 119 
TYR 24 (3) 35 (1) 36 (1) 46 (2) 55 (3) 89 (4) 91 (3) 100 (2) 103 (2) 112 (1) 
TYRP1 30 (1) 41 42 56 65 99 101 110 113  122 
DiS  1 1 2 3 2 3 4 4 5 5 
 
Cysteines in the Cys-rich domain are renumbered C1 to C10 to facilitate correspondence 
between the 3 enzymes. C3 to C8 are part of the EGF-like signature. The DCT/TYRP2 
patients’ mutations are therefore in C2 (Cys40Ser) involved in Disulfide bond (DiS) 1 (light 
gray) for patient 1, and C5 (Cys61Trp) involved in DiS 2 (dark grey) for patient 2. Cys 
residues that have been seen mutated in OCA1 (TYR) or OCA3 (TYRP1) patients are 
indicated in bold and the number of different allelic variants described in the Human Gene 
Mutation Database (HGMD) are indicated in parentheses. Mutations in TYR and TYRP1 that 
affect the same DiS bond and are therefore likely to result in a same functional consequence 



































SUPPLEMENTARY MATERIALS AND METHODS 
 
Sequencing of the candidate genes, bioinformatics analysis. 
DNA samples were quantified using the Qubit™ dsDNA HS Assay Kit on the Qubit® 2.0 Fluorometer 
(Life Technologies) and diluted to a final concentration of 10 ng/µL. Amplicons (libraries) were 
generated with the Ion AmpliSeq™ Library Kit 2.0 and then quality-checked and quantified on the 
2200 TapeStation (Agilent, U.S.A.). Emulsion PCR and enrichment were performed on the Ion CHEF 
System (Life Technologies) using the Ion 520/530 Kit Chef. Two Ion 530 chips (Life Technologies), 
each containing 24 patients, were sequenced per run. 
Pathogenicity of single nucleotide variants was evaluated using bioinformatics tools Cartagenia 
BenchLab NGS (Agilent Technologies) and Alamut Visual (Interactive BioSoftware, Rouen, France) 
based on criteria including allele frequency (gnomAD http://gnomad.broadinstitute.org, ESP 
evs.gs.washington.edu/EVS, dbSNP www.ncbi.nlm.nih.gov/SNP), description in database (HGMD 
Professional www.biobase-international.com/product/hgmd), conservation, pathogenicity prediction 
algorithms (Polyphen genetics.bwh.harvard.edu/pph2, SIFT sift.bii.a-star.edu.sg, Mutation Taster 
www.mutationtaster.org, GVGD agvgd.iarc.fr) and effect on splicing (SSF 
www.genet.sickkids.on.ca/~ali/splicesitefinder.html, HSF www.umd.be/HSF3, MaxEntScan 
genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.htm, NNSplice 
www.fruitfly.org/seq_tools/splice.html, GeneSplicer ccb.jhu.edu/software/genesplicer). 
DCT variants (NM_001129889.2) found by NGS were confirmed by Sanger sequencing (BigDye® 
Terminator v3.1 Cycle Sequencing Kit; Applied Biosystems®, ThermoFischer Scientific) on a 3500xL Dx 
Sequencer (Life Technologies, ThermoFischer Scientific) using primers 
AGGAGAAAAGTACGACAGAGACA and TCCGACCAAAACCATCATTG (exon 1) and 




CRISPR modelling of Dct variants in the mouse. 
Mouse lines: To create the Dct118 A/A, Dct183 G/G and Dct -/- alleles the CRISPR design site 
https://chopchop.cbu.uib.no/ (in the public domain) was used to design guides with default settings 
(g1 for Dct118 A/A :  CTTGGATGGCGTGCTGAACAAGG ; g2 for Dct183 G/G and Dct -/- : 
GTGGATTTCTAGAGGGCAGGGGG). Guides were in vitro transcribed using GeneArt Precision gRNA kit 
(Invitrogen, A29377). Guide RNAs along with GeneArt Platinum Cas9 Nuclease (Invitrogen, B25641) 






GTGGCCCTTATATCCTTCGAAACCAGGATGACCGTGAGCAATGGCCGAGAAAATT, synthetized by IDT), was 
used for pronuclear injection into C57BL/6J zygotes. The injected eggs were cultured overnight to the 
two-cell stage and then transferred into pseudopregnant females. Pups were screened for the 
mutations by sequencing PCR fragments generated using primers Dct1_F and Dct1_R (Dct_1_F 
GCCAGGCCTCCCAATTAAGA and Dct_1_R GCCCTCACCTGTGCATTTG) and lines established carrying 
the targeted missense mutations and one 5 nucleotide deletion, resulting in frameshift. Genotyping 
was done by PCR, and then Sanger sequencing, using primers Dct1_F and Dct1_R. All lines were 
maintained on the C57BL/6J mouse strain background.  
Direct spectrophotometry of Dct mice: Coat colour of live mice, aged between 1 and 2 months, was 
measured by direct spectrophotometry using Konica Minolta CM-2600d. Measurement of mouse’s 
dorsal coat colour was carried out in triplicate and the mean values of these measurements were 
plotted onto a 3D graph of CIELAB colour space using Rstudio with plot3D package.  
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Eye histology:  Mice were sacrificed by cervical dislocation and eyes enucleated and placed into 
Davidson's fixative (28.5% ethanol, 2.2% neutral buffered formalin, 11% glacial acetic acid) for 
overnight. Prior to wax embedding, eyes were dehydrated through an ethanol series. Hematoxylin 
and eosin staining was performed on 5- or 10-μm paraffin-embedded tissue sections and images 
captured using a Nanozoomer XR scanner (Hamamatsu, Hamamatsu City, Japan) and viewed using 
NDP.view2 software (Hamamatsu). 
 
dct knock-down in Danio rerio. 
dct targeting: Zebrafish (D. rerio) were produced in our facilities, in accordance with the French 
Directive (Ministère de l'Agriculture) and in conformity with the European Communities Council 
Directive (2010/63/EU). The zebrafish homolog of human DCT was identified by searching in the 
genome sequence database at http://www.ensembl.org/Danio_rerio taking in account the synteny 
with the human genome. Morpholinos (MO) were designed by and obtained from GeneTools, LLC. A 
specific MO to dct gene, MO-DCT, was designed as complementary to the sequence flanking the 
translation initiation codon of dct (5’-GCGCTT[CAT]TTCTGCGAAAACACAG-3’, brackets indicate the 
initiation codon complementary sequence). Standard control MO from Gene Tools LLC (5’-
CCTCTTACCTCAGTTACAATTTATA-3’) was used as negative control. MOs were injected at the 1-2 cells 
stage with 1.5ng/embryo. Embryos were then incubated at 28°C. Embryos were imaged under a 
stereomicroscope. Length and left eye area were measured using ImageJ software. 
Melanin assay: Ten embryos at 48 hpf stage were transferred in Tris pH=7.5 50mM, EDTA pH=8 
2mM, NaCl 1mM, Triton X-100 1% and incubated 5 min at 4°C for lysis. Lysates were centrifuged for 
10 min, 14000 rpm, 4°C. Supernatants were processed for classical protein assay. Pellets were 
dissolved in 1N NaOH. Standard solutions of melanin and samples were heated at 100°C for 10 min 
and processed for melanin assay by absorbance determination at 490 nm. Melanin content was 
normalized to protein content.  
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Histological analysis: Zebrafish embryos were fixed with 4% PFA in PBS at 4 °C overnight, embedded 
in paraplast and sectioned at 10 µm.  After rehydration, sections were stained with toluidine blue 






Supplementary Table 1: Candidate genes tested in this study. 
 
 
GENE PROTEIN MOUSE MUTANT 
AP1B1 Adaptor Protein 1 complex subunit beta-1   
AP1G1 Adaptor Protein 1 complex subunit gamma-1   
AP1G2 Adaptor Protein 1 complex subunit gamma-2   
AP1M1 Adaptor Protein 1 complex subunit mu-1   
AP1M2 Adaptor Protein 1 complex subunit mu-2   
AP1S2 Adaptor Protein 1 complex subunit sigma-2   
AP1S3 Adaptor Protein 1 complex subunit sigma-3   
AP3B2 Adaptor Protein 3 complex subunit beta-2   
AP3M1 Adaptor Protein 3 complex subunit mu-1   
AP3M2 Adaptor Protein 3 complex subunit mu-2   
AP3S1 Adaptor Protein 3 complex subunit sigma-1   
AP3S2 Adaptor Protein 3 complex subunit sigma-2   
ATP7A ATPase copper transporting alpha mottled 
BLOC1S1 Biogenesis of lysosome-related organelles complex subunit 1   
BLOC1S4 Biogenesis of lysosome-related organelles complex subunit 4 cappuccino 
BLOC1S5* Biogenesis of lysosome-related organelles complex subunit 5 muted 
DCT Dopachrome tautomerase slaty 
DOCK7 Dedicator of cytkinesis 7 misty 
FIG4 Phosphoinositide 5-Phosphatase pale tremor 
KIF13A Kinesin Family Member 13A   
PMEL Premelanosome Protein silver 
RAB38 Ras-related protein RAB38 chocolate 
RAB27A Ras-related protein RAB27A ashen 
RABGGTA Rab geranyl geranyl transferase gunmetal 
SLC7A11 Solute carrier family member 11 subtle gray 
VPS33A Vacuolar protein sorting-associated protein 33A buff 
 
* Analysis of our cohort of patients identified pathogenic variants in BLOC1S5 in two unrelated 
patients. Pennamen et al. BLOC1S5 Pathogenic Variants Cause a New Type of Hermansky-Pudlak 
Syndrome. Genet Med. 2020 Jun 22. doi: 10.1038/s41436-020-0867-5. 
 
 
 
